The Aryl Hydrocarbon Receptor (AhR) is required for the toxicity of TCDD, and so the AhR of CRL:WI and CRL:WI(Han) rats was characterised. Western blot showed AhR proteins of ~110 and ~97 kDa in individual rats from both strains. The AhR cDNA from a CRL:WI(Han) rat with the ~110kDa protein revealed a sequence that was identical to that of the CRL:WI and SD rat.
INTRODUCTION
is a ubiquitous toxin, and a prototypical representative of a series of chemicals which effect toxicity through a common mechanism, binding to the Aryl Hydrocarbon Receptor (AhR) (Poland et al., 1976a) (Poland and Knutson, 1982) . Research has focussed on the toxicity of TCDD, on the basis that other chemical congeners will
show the same toxicity as TCDD, but will merely have different potency (Van den Berg et al., 2006) . Mouse genetic studies demonstrated that dioxin toxicity is mediated through the AhR locus (Poland and Knutson, 1982) . The subsequent cloning of the AhR (Burbach et al., 1992 ) (Ema et al., 1992) characterised the AhR as a transcription factor. The creation of AhR knockout mice enabled the confirmation that AhR was required for dioxin toxicity (Fernandezsalguero et al., 1995) (FernandezSalguero et al., 1996) (Schmidt et al., 1996) (Shimizu et al., 2000) , and specific alterations in the AhR control dioxin-mediated toxicity (Walisser et al., 2004) (Bunger et al., 2003) .
Maternal dosing with low doses of TCDD during pregnancy is reported to cause adverse effects in the reproductive system of male offspring, notably decreased sperm count in the cauda epididymis of Holtzmann (Mably et al., 1992) or Wistar (Faqi et al., 1998) rats. These effects were used to set a Tolerable Daily Intake of 2pg kg -1 day -1 for TCDD and related compounds by the UK Committee on Toxicity (Committee on Toxicity, 2001 ). Subsequent studies have failed to reproduce these effects in Holtzmann rats (Ikeda et al., 2005) (Ohsako et al., 2001) . We undertook studies in the Wistar(Han) rat (CRL:WI(Han)), and showed that TCDD did not cause potent developmental effects on offspring sperm levels at postnatal day 120 (Bell et al., 2007a ) (Bell et al., 2007b ) (Bell et al., 2007c) . During the course of these studies, it became clear that there was a size polymorphism in the AhR of the CRL:WI(Han) rat (MQF, DRB, unpublished data). There was therefore a concern that the size polymorphism of the AhR protein might reflect a different AhR allele, and that the different AhR alleles might control TCDD toxicity in this system.
The Wistar(Han) (Kuopio) rat is resistant to specific toxic effects of TCDD ) (Pohjanvirta et al., 1987) , and one allele for resistance to the acute lethality of TCDD in a Long-Evans x Wistar(Han) cross was subsequently shown to co-segregate with an
AhR allele (Pohjanvirta, 1990 ) , suggesting that the AhR allele was responsible for the phenotype. The polymorphism in the Wistar(Han) (Kuopio) AhR has been characterised (Moffat et al., 2007) (Pohjanvirta et al., 1998) . However, it was discovered that JIANG ET AL. THE WISTAR(HAN) AHR AND TOXICITY 26/11/08 Page 4 the original rat strains used were an inbred Long-Evans line, and a small colony of outbred Wistar(Han) rats (derived from Zentralinstitut für Versuchstierzucht GmbH, Hannover, FRG). The inbred Long-Evans rats had significantly different susceptibility to the acute lethality of TCDD compared with outbred Long-Evans rats, and the small Finnish colony of Wistar(Han) rats had different susceptibility to the acute lethality of TCDD, compared to a different batch of Wistar(Han) rats (Pohjanvirta and Tuomisto, 1990) , and hence the Finnish rats were named as the inbred L-E (Turku/AB) and outbred H/W (Kuopio) strains. It is therefore not clear to what extent the characteristics of the Kuopio strain of Wistar(Han) rats are representative for other Wistar(Han), or Wistar, strain rats. Given that the AhR hw allele confers ~100-fold resistance to the acute lethality of TCDD in adults, there was the possibility that this AhR allele might be present, and have affected the developmental toxicity of TCDD in our study in Wistar(Han) rats.
Given that AhR polymorphisms are known to be determinative of TCDD-induced toxicity in the mouse, we therefore sought to investigate the AhR of the CRL:WI(Han) rat, whether there were any genetic polymorphisms in AhR, and characterising what those polymorphisms were.
Any polymorphisms might have affected the toxicity of TCDD in our studies with this rat strain (Bell et al., 2007a ) (Bell et al., 2007b ) (Bell et al., 2007c) , and so we investigated whether polymorphic AhR variants have altered affinity for TCDD, and whether these polymorphisms in the AhR of the CRL:WI(Han) rat are associated with susceptibility to the developmental toxicity of TCDD in two separate studies.
MATERIALS AND METHODS
All chemicals were of the highest quality available. Rats of three strains: Wistar (CRL:WI), Wistar (Han) (CRL:WI(Han)) and Sprague-Dawley (CRL:CD(SD)) were all from Charles River Laboratories, UK. Samples of CRL:WI(Han) liver were obtained from previously described studies on the developmental toxicity of TCDD (Bell et al., 2007b ) (Bell et al., 2007c) ; samples from these studies which were analysed for RNA levels (Bell et al., 2007a) were selected for genotyping.
Western blotting. Rats were killed by barbiturate overdose and the liver perfused with ice-cold MDEG buffer (25mM MOPS, pH 7.5, 1mM DTT, 1mM EDTA, 10% glycerol). The liver was flash frozen in liquid nitrogen and stored at -80ºC for later use. An aliquot of frozen liver was homogenized with 6 volumes of MDEG buffer containing 20mM sodium molybdate. Cytosol was prepared by an initial centrifugation at 10,000g for 10 minutes, and the resulting supernatant was centrifuged again at 240,000g for 30 minutes. The cytosol was collected and protein concentration was determined by a Bradford Assay using BSA as a reference. Protein (60μg/ lane) was separated on a polyacrylamide gel electrophoresis (PAGE) (either SDS-PAGE, or pre-cast gels (Invitrogen) using lithium duodecyl sulphate) and transferred to a PVDF membrane (Immobilon, USA). Signal was detected using Enhanced Chemiluminescence (ECL; GE Healthcare) and exposed to a film. The antibody against AhR has been previously described (Fan et al., 2008) .
Cloning of CRL:WI(Han) AhR. Livers from CRL:WI(Han) rats expressing either the lower or higher Mr AhR were selected for gene cloning. Total RNA was extracted from frozen rat liver tissue using Trizol reagent, and PolyA+ mRNA was isolated from total RNA using Oligotex Direct mRNA Kits (Qiagen) according to manufacturers' protocol. Reverse transcription was performed with Enhanced Avian RT First Strand Synthesis Kit using oligo (dT) 23 as primer. The full length coding region of the AhR was obtained in three fragments (Fragments1-3) using PCR primers based on the sequence for CRL:WI rat AhR; the primers are shown in Table 1 . JumpStart AccuTaq LA DNA Polymerase Mix (Sigma) was used for PCR and the products were subcloned into pGEM-T plasmids (Promega). The inserts were verified by double stranded DNA sequencing. Three fragments of each variant previously separately cloned in pGEM-T plasmids were used to produce full length AhR by restriction digest with appropriate enzyme and ligation.
In order to facilitate in vitro expression of the AhR variants, a Kozak consensus sequence was introduced into 5'-end of the full length AhR by PCR with primers NOTKFW and APARV ( The gel was dried and exposed to a film or phosphor imaged.
Plasmid construction. Methods were essentially as described (Fan et al., 2008) . Full length rat
AhR variants (Wild-type, Deletion and Insertion) were cloned into pGEM-T Easy. A His 6 tag was introduced at the C-terminus by PCR with forward primer rBam-5 (AhR bases and backward primers rHis-3-Del or rHis-3-Ins (Table 2) . Fragments were gel-purified, and cloned into plasmid pGEM-T Easy (Promega), and checked by double strand sequencing. There was a single mutation (A2336G) in rAhR deletion variant sequence, and site-directed mutagenesis was used to change this mutation. QuikChange Site-Directed mutagenesis kit was pur- (Poland et al., 1976a) , as amended by (Fan et al., 2008) (Poland et al., 1976b) at 4°C overnight. After incubation, 30μl of dextran-coated charcoal suspension (67mg/ml, prepared in MDEG buffer) was added into a 200μl sample of the mixture.
The suspension was incubated on ice for 10min, and then was centrifuged at 25,000g for 10min.
150μl of the supernatant was removed and radioactivity was measured in a scintillation counter.
Specific binding was defined as the difference of radioactivity between without (total binding) and with competitor TCAOB (non-specific binding). For recombinant rat AhR protein, either 0.25mg or 0.5mg/ml cytosol protein was used for binding assay, and supplemented with BSA to a final protein concentration of 5mg/ml. Specific saturable binding (K d ) was characterised by using non-linear regression, using Graphpad 4/5, fitting a saturation binding isotherm.
SNP detection in genomic DNA. Genomic DNA was extracted from 20-25mg of frozen tissue with 0.6ml of lysis buffer (10mM Tris-HCl, pH 7.5; 400mM NaCl; 100mM EDTA; 0.6% SDS) containing 0.35mg of proteinase K. The sample was incubated at 60°C for 16 hours, to which 0.2ml of 5M NaCl was added at the end of the incubation, and centrifuged for 10 minutes at 10000g. The DNA containing supernatant was collected and precipitated by adding equal volume of ice cold 90% ethanol followed by centrifugation. The resulting DNA pellet was washed with cold 75% ethanol and air dried. The DNA pellet was then resuspended in 100μl water. Statistical methods. K d values for the affinity of AhR for TCDD were compared using a t-test.
Observed genotype frequencies were compared with expected allele frequencies, including those expected under Hardy-Weinberg equilibrium, using a Pearson χ 2 statistic. Previous analyses of body and organ weights and measures of reproductive toxicity in acute and chronic dosing experiments (Bell et al., 2007b ) (Bell et al., 2007c ) examined dose-response relationships by ANOVA methods, including mixed models with random effects terms for litter effects.
These responses were reanalysed, for those animals and tissues for which genotyping had been carried out, under the same models but with an additional factor representing the genotype as wild type, mutant or heterozygous. Interest was specifically in whether the different types had different susceptibility to the effects of TCDD, and this was examined by fitting interaction terms between TCDD dose and genotype. The data set from the animal studies, together with the genotyping and RNA data, is provided in Supplementary data as an Access database.
RESULTS
Whilst preparing cytosol for analysis of ligand-binding to [ 3 H]-TCDD from CRL:WI(Han) rats, it was noted that there were multiple size variants of the AhR immunodetected in Western blots, with protein sizes of ~110 and ~97 kDa (Fig. 1A ). These size variants were reproducible in cytosol preparations from an individual rat; moreover, the banding pattern was unchanged by the inclusion of protease inhibitors during cytosol preparation, or to optimisation of the denaturing conditions for SDS-PAGE (Data not shown). Cytosol from Sprague-Dawley rat liver (Fig. 1A) (and C57Bl/6 and DBA/2J mouse liver, (data not shown)) consistently produced an AhR protein of the expected size, suggesting that the different protein bands were not a product of proteolysis, but were intrinsically different AhR forms. The phenomenon is not restricted to the CRL:WI(Han) rat, since the CRL:WI rat also shows two AhR size variants in hepatic cytosol
Cloning of variant AhR cDNAs from CRL:WI(Han) rat
To determine if the differently-sized AhR protein variants were the result of different mRNA sequences, AhR cDNAs were cloned from CRL:WI(Han) rats that were known to have either a 110 kDa or 97 kDa protein product. Double-stranded sequencing of AhR clones from rats with the 110 kDa AhR protein revealed that the sequence was identical to that of the CRL:WI (AJ821851) and Sprague-Dawley rat (AAA56897), yielding a protein of 853 amino acids (Accession number AM902286). This AhR sequence is hereinafter referred to as the wild-type sequence. However, there were five variants in the AhR clones from the rat with the 97 kDa AhR protein, as shown in Fig. 2 ; at least two independent cDNAs of each variant were sequenced.
These have a common Val497Ala point mutation, and the multiple cDNA variants are consistent with a point mutation at the end of exon 10 of the AhR, causing the use of alternative splicing sites (Pohjanvirta et al., 1998) 
Recombinant expression and properties of variant AhR cDNAs
The recombinant cDNAs were cloned and expressed in reticulocyte lysates to determine their size, and whether the Insertion and Deletion variants were viably translated, and could be distinguished on SDS-PAGE. Fig. 3A shows that both the Insertion and Deletion cDNAs produced a protein of the expected size, but that these could not be distinguished from one another on SDS-PAGE. By contrast, the wild-type protein migrated more slowly than the variant alleles.
To confirm this, the proteins were then expressed using the baculovirus expression system, and cytosolic extracts prepared and analysed by western blotting with an AhR specific antibody. To test if there was any difference in ligand-binding functionality of the AhR alleles, a previously validated baculovirus expression system for AhR was used (Fan et al., 2008) . The AhR proteins expressed in baculovirus were assayed for the ability to bind TCDD as a ligand (Fig. 4) .
The ligand-binding assay showed saturable and specific binding, and gave values for rat liver cytosol which are consistent with the literature (data not shown). Although the maximal amount of specific binding (B max ) varied between batches by two-three fold, the affinity of the ex- 
An SNP assay for AhR alleles
In order to be able to determine if the AhR alleles were able to affect susceptibility to toxic endpoints in our studies (Bell, et al., 2007a; Bell, et al., 2007b; Bell, et al., 2007c) , it was necessary to develop an SNP assay to discriminate between alleles. Molecular beacon technology (Marras et al., 1999) was used to probe the allelic variant at the exon 10 junction, in a 108bp amplicon.
The Molecular Beacons were designed to discriminate between the the wild-type (G) or mutant (A) allele at the 1st nucleotide of intron 10 in the rat AhR ( Table 1 ); note that this assay does not differentiate between the Insertion and Deletion transcripts, which are produced as a result of post-transcriptional processing. Initial hybridisation studies with the probes showed discrimination between wild-type and mutant allele oligonucleotides, with strong signal to the matching probe, minimum signal from the mismatched oligonucleotide, and hence maximum discrimination at 52°C (data not shown). The optimised PCR reaction (Fig. 5A-C) shows that both probes can be used in the same PCR reaction to yield unambiguous discrimination between wild-type and mutant alleles in genomic DNA. There was clear discrimination between wildtype, mutant and heterozygote DNA samples when using large numbers of samples (Fig. 5D ), and hence this assay was validated to analyse the tissue samples available from our previous in vivo studies.
Analysis of the populations from the acute and chronic studies was divided up into the maternal and offspring, since the offspring represent a dependent population ( Table 2) A sampling of 51 CRL:WI rats, of unknown inter-relationships, found that there was a significant deviation from the expected 1:2:1 genotype ratio (χ 2 =25) (Table 2 ). However, the genotype frequencies in this population did not deviate significantly from a Hardy-Weinberg equilibrium (χ 2 =2.9), and thus there is no evidence for systematic skewed representation of the homozygous AhR alleles in the CRL:WI rat.
Association between AhR genotype and toxicity
In the analysis of phenotypic endpoints in the acute (Bell et al., 2007b) and chronic (Bell et al., 2007c ) studies on TCDD developmental toxicity, with a view to determining if the toxicity in these studies was affected by genotype at the AhR locus, there was a prior expectation that any biologically relevant interaction between treatment and genotype would show a similar size and direction of effect between the acute and chronic studies, and would show an appropriate dose-dependency of effect. The full dataset is provided as an access database, and the summary statistical analyses are provided as a Table for each endpoint (Supplementary Material). The principal toxic effects seen in those studies were reduction in body weight gain in the F1 animals, delay in balano-preputial separation, and total litter loss in the offspring. It was not possible to assay the animals which had died as a result of total litter loss, since no samples of the dead animals were taken, but the other measures of toxicity were examined. Maternal cytochrome P450
1A1 (CYP1A1) RNA levels (Bell et al., 2007a) showed no significant correlation with genotype in either the acute or chronic study. In the offspring, CYP1A1 RNA levels at PND70 showed no correlation with genotype in the chronic study, but there was a significant association (P~0.019) between genotypes in the acute study, with heterozygous animals having 1.7-fold, and homozygous mutant animals having 2.5-fold the level of CYP1A1 RNA as homozygous wild-type animals. Given the relatively low levels of CYP1A1 RNA in rats at PND70, the fact that the mutant appears more responsive than wild-type, the small size of the effect, and the lack of effect in the chronic study, or the mothers, it is likely that this association is due to chance.
Balano-preputial separation was found to be significantly delayed by TCDD treatment in both studies (Bell, et al., 2007b; Bell, et al., 2007c) , but there was no significant association between genotype and day of balano-preputial separation. Liver: body weight ratio is also a classical marker of TCDD toxicity and AhR function (Bunger, et al., 2003; Schmidt, et al., 1996) , but rat genotype showed no significant association with liver: body weight ratio. There was a statistically significant association between genotype and spleen: body weight ratio in the chronic study at PND 70, but not PND120, but there was no interaction with dose, nor an effect on spleen: body weight ratio in the acute study at any age (Supplementary Material).
F 1 offspring were identified individually from PND21 onwards, and body weights after this time were affected by TCDD treatment of the dams. There was a statistically significant association between genotype and body weight in the chronic (P~0.015), but not the acute, study.
However, a plot of the difference in weight between homozygous wild-type and mutant alleles by dose group, revealed no biologically plausible, or consistent, response (see Supplementary   Tables, and Supplementary Figures 1 and 2) . With the body weight data set, there was a significant association between post-natal day and genotype for the chronic study (but not the acute), and for group and genotype for the acute study (but not the chronic study), and a significant association between post-natal day, group and genotype for both studies. However, a plot of the data did not show any consistent or plausible effect of genotype on body weight. Thus there was
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DISCUSSION
We discovered that the Wistar strain rats used in our previous studies (Bell et al., 2007a ) (Bell et al., 2007b ) (Bell et al., 2007c) had two size variants of the AhR protein present in liver cytosol, and have shown that the size variants are the result of a genetic polymorphism of the AhR present in CRL:WI and CRL:WI(Han) rats (Fig. 1, Fig. 2 ). The discovery of this genetic polymorphism in the AhR raised the possibility that it could be determinative of the function of the AhR, as is known for the AhR b/d polymorphisms in the mouse (Poland et al., 1994) . The murine AhR polymorphisms are known to affect the affinity of the AhR protein for the ligand, TCDD (Harper et al., 1988 ) (Poland et al., 1994) , and since the binding of ligand to the receptor is a rate-limiting step for the function of the receptor, a change in the affinity of the AhR for ligand would inevitably impact upon the function of the receptor. In order to test this possibility, we undertook recombinant expression of the variant AhR proteins produced. Both deduced protein sequences gave rise to a protein product (Fig. 3 ), and they were both shown to encode a functional ligand-binding AhR, with affinity for TCDD that was statistically indistinguishable from the affinity of the wild-type AhR (Fig. 4) . This extends the finding that the affinity for TCDD (K d ) of cytosol from Long-Evans (Turku AB) and Wistar(Han) (H/W(Kuopio)) rats was similar . The ligand-binding domain of the AhR resides in a minimal domain of amino acids 228-416 (Bell and Poland, 2000) (Coumailleau et al., 1995) (Poland et al., 1994) ; since the polymorphisms in the rat AhR are at amino acid 497, and at the C-terminus (the transactivation domain), our data confirms that the sites of allelic variation are outside the domain responsible for ligand-binding.
Western blotting shows that both AhR alleles are present in the CRL:WI and WI(Han) stock, but the allele frequency in Wistar strain rats was unknown. Molecular beacon technology (Marras et al., 1999) was developed for a robust and rapid SNP assay (Fig. 5 ). This methodology enabled the determination that both alleles were present in both CRL:WI, and CRL:WI(Han) rats, at ratios that were not divergent from the Hardy Weinberg equilibrium; thus there is no evidence for systematic under-representation of the homozygous mutant allele, for example. Given the severe physiological consequences of a null AhR allele in mouse (Bunger et al., 2003) (Faqi et al., 1998 ), and we undertook our studies (Bell et al., 2007a ) (Bell et al., 2007b ) (Bell et al., 2007c) in the CRL:WI(Han) rat since (a) it was not possible to use the Wistar strain used by Faqi (b) there was extensive background information on the CRL:WI(Han) strain in house (c) the Wistar(Han) strain is derived from the Wistar strain. Although Table 2 shows the chronic study F 1 rats had a significant difference from the equilibrium 1:2:1 AhR genotype, this was not true for the chronic P 0 dams, or in the acute study. Thus both alleles are prevalent in CRL:WI and CRL:WI(Han) populations, and these findings are likely to be informative for many Wistar colonies. However, it is important to note that inappropriate breeding strategies or chance may result in the exclusion of one of the AhR alleles from an individual Wistar colony. Studies in Wistar strain rats on the toxicity of TCDD, or similarly acting compounds, may be affected by the presence of allelic variants of the AhR (Banudevi et al., 2006) (Taketoh et al., 2007) .
Toxicity endpoints from data in (Bell et al., 2007a ) (Bell et al., 2007b ) (Bell et al., 2007c) were correlated with rat genotype (Table 2 ). In view of the known pitfalls of undertaking multiple statistical tests (Ioannidis, 2005) (Ioannidis et al., 2001) , the analysis was restricted to a discrete series of endpoints that were set out in advance. The AhR alleles did not have a significant association with liver: body weight ratio, and this suggests that the variant rat allele is sufficiently functional to support the normal vascularisation of the liver (Schmidt et al., 1996) (Walisser et al., 2004) . There was no plausible association of AhR allele on induction of cytochrome P450 1A1 RNA, or between AhR allele and body weight or balano-preputial separation, the two most sensitive markers of TCDD-induced toxicity in the developmental studies (Bell et al., 2007c) .
The absence of any plausible and statistically signficant association between AhR genotype and toxicity endpoints makes a compelling case that there was no causal effect of the AhR allele on the toxicity of TCDD resulting from developmental exposure of male pups (Bell et al., 2007a ) (Bell et al., 2007b ) (Bell et al., 2007c) . Therefore the conclusions derived from the studies of TCDD developmental toxicity do not require reinterpretation to accomodate the effect of AhR genotype, as there was no evidence to support an effect of AhR genotype on TCDD developmental toxicity (Bell, et al., 2007a; Bell, et al., 2007b; Bell, et al., 2007c) .
We have described developmental toxicity of TCDD (lethality, developmental delay and depressed body weight) after a single maternal dose of 1 μg kg -1 (Bell et al., 2007b) or 46 ng kg -1 day -1 (Bell et al., 2007c) in CRL:WI(Han) rats; which is exquisitely sensitive in comparison to the acute lethality at >10,000 μg TCDD kg -1 in adult rats with the AhR hw allele . It is startling that the AhR hw allele can confer such marked resistance to lethality of TCDD in adults, yet have no effect on the much more sensitive endpoint of developmental toxicity (this study). A particular strength of the approach in this study is that all of the animals shared the common genetic background of the CRL:WI(Han) rat, and this contrasts with the A, B and C lines of , which are descended from a cross between an inbred Long-Evans and Han/Wistar(Kuopio) rats. Although the Ahr hw and "B" genes have been shown to segregate with susceptibility to the acute lethality of TCDD in the Long-Evans x Han/Wistar(Kuopio) cross of , it is clear that these genes do not determine susceptibility to all other toxicities arising from TCDD exposure . Consequently, it is entirely possible that other genetic loci could be determinative for particular TCDD-induced toxicities, and that they could differ between the parental L-E (Turku/AB) and H/W (Kuopio) strains, and in the derived lines. There is evidence for differential developmental toxicity of TCDD between the two parental lines (Huuskonen et al., 1994) , and thus any differential response of the A-C lines to developmental toxicity does not necessarily demonstrate a role for the Ahr hw or "B" genes (Simanainen et al., 2004) . This study therefore provides clear evidence from a study in the common genetic background of the CRL:WI(Han)
rat that the wild-type and mutant AhR alleles did not measurably affect multiple parameters of TCDD-induced developmental toxicity in two separate studies (Bell et al., 2007a ) (Bell et al., 2007b ) (Bell et al., 2007c) . The disparity in the data on genetic linkage between susceptibility to TCDD-induced developmental toxicity or acute lethality makes a compelling case for using definitive transgenic approaches to determining whether the AhR hw confers resistance to TCDD-induced lethality.
In summary, there is an allelic form of the AhR which is common in CRL:WI(Han) and CRL:WI rats, and the allele results in alternative splicing and C-terminal truncation, together with an amino acid mutation, in the AhR. The variant allele yields two C-terminally truncated proteins, but does not affect the affinity of AhR for the ligand, TCDD. The allele does not show a plausible association with endpoints of TCDD-induced developmental toxicity in two independent studies, and our data therefore shows that this AhR allele did not affect TCDD-induced developmental toxicity in our previous studies (Bell et al., 2007a ) (Bell et al., 2007b ) (Bell et al., 2007c) . Genetic linkage data show a marked difference in the association of AhR hw on susceptibility with TCDD-induced acute lethality, or developmental toxicity, and this study calls into question whether the reported association with AhR hw is an effect of a linked gene, or the AhR hw allele. variants of the CRL:WI(Han) AhR were cloned into pFASTBAC1, and then used to make baculovirus as described in materials and methods. The viruses were used to infect cells, and compared with uninfected cells (Sf9), by SDS-PAGE of 10μg of cytosolic protein, followed by western blotting with an AhR-specific antibody. Visualisation was with ECL. The size of molecular weight markers is shown in kDa (Mr, Kda).
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FIG. 4. Saturation ligand-binding analysis of AhR variants. Wild-type, Insertion (Ins) and
Deletion (Del) variants of the CRL:WI(Han) AhR were cloned into baculovirus as described in 
TABLES

SNP66 (f) CAGTACAGCCCTGAGATTCCAG
SNP150 (r) ACACAATAGACTACACGGAGATGC
WtMB
FAM-CACCCGCTAAGCAAGGTAAGGGCTCGGGTG-BHQ1
MutMB
HEX-CACCCGCTAAGCAAGATAAGGGCTCGGGTG-BHQ2
Wt-Temp AGCCCTTACCTTGCTTAG
Mut-Temp AGCCCTTATCTTGCTTAG
Sequence of oligonucleotides used in this study. The designation of the oligonucleotide is shown together with the corresponding sequence. HEX (6-Hexachloro-Fluorescein-CE Phosphoramidite) and FAM (6-carboxyfluorescein) represent the 5' fluorescent groups, and the BHQ1/2 groups at the 3' end are "Black Hole Quencher" moieties. Tissue samples were analysed by PCR for the presence of wild-type, homozygous mutant or heterozygous mutant alleles, as described in Fig. 5 . Animal samples were parental GD16 or 21 kills (P 0 ) or offspring (F 1 ) from the acute dose (Bell et al., 2007b) (Acute) or chronic dose (Bell et al., 2007c ) (Chronic) studies. The total number of animals is indicated in brackets. Thirty non-sibling CRL:WI(Han) were obtained from Charles River for a sampling of the stock, and CRL:WI animals were of unknown sibling status were obtained over a period of months, prior to analysis. The number of wild-type, heterozygous or homozygous mutant animals are shown, and this is shown as a ratio in the right-most column, with the wild-type ratio set as one. There was a significant effect of dose group, and genotype, in the chronic study at the 10 week kill, but not at 17 weeks, and there were no significant effects in the acute study on these param- There are multiple significant effects of PND, Group and genotype in both studies, and interactions between these variables. To determine if these effects were likely to be plausible, the difference between the weight of the wild-type group, and the homozygous (supplementary Figure   1 ) or heterozygous (Supplementary Figure 2) mutants was plotted for each dose group as a function of post-natal day for each study. Supplementary Figure 2 shows absolutely no biologically plausible relationship between dose group, genotype, and post-natal day; moreover, the magnitude of changes is from +20g to -30g. Supplementary Figure 1 
